Related Experiment Video
Updated: Feb 14, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Targeted palliative care day therapy interventions using modified MYMOP2 tool can improve outcomes for patients with
Daniel Monnery1, Esther Webb2, Lorna Richardson3
1Registrar in Palliative Medicine, Clatterbridge Cancer Centre, Wirral, UK.
Background:
There is a paucity of evidence supporting the benefits of palliative care day therapy services for patients with non-malignant diseases. Outcome measures in this setting are also lacking.
Aim:
To evaluate the use of the modified Measure Yourself Medical Outcome Profile 2 (MYMOP2) tool in tailoring day therapy services toward the needs of patients with non-malignant conditions Method: A single system, 'before and after' design quality improvement study was conducted. Data were collected regarding outcome measures, re-referral rates and mortality.
Result:
After the introduction of the modified MYMOP2 tool, there was an improvement in the mean outcome scores for patients with non-malignant disease. Re-referral rates for these patients dropped by 28% during the follow up period, with no change in mortality.
Implications For Practice:
These findings suggest that using the modified MYMOP2 tool to tailor and measure the outcome of holistic day therapy services results in a more sustained improvement for patients with non-malignant disease.
More Related Videos
Related Concept Videos
Patient-centered Care
Targeted Cancer Therapies
There are several types of targeted therapies against...
Coronary Artery Disease V: Interprofessional Care
Gene Therapy
Chronic Kidney Disease III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care

